Black Rock Inc. Relay Therapeutics, Inc. Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 10,542,667 shares of RLAY stock, worth $45.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,542,667
Previous 9,796,210
7.62%
Holding current value
$45.8 Million
Previous $81.3 Million
15.46%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RLAY
# of Institutions
204Shares Held
156MCall Options Held
207KPut Options Held
40K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$121 Million1.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.5MShares$62.8 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY9.25MShares$40.1 Million5.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.38MShares$32 Million0.88% of portfolio
-
Jpmorgan Chase & CO New York, NY5.52MShares$23.9 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $522M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...